Back to School: How biopharma can reboot drug development. Access exclusive analysis here

AMG0001 HGF plasmid: Additional Phase III data

Additional interim data from a double-blind, Japanese Phase III trial showed that ischemic ulcers improved in all 11 AMG0001 patients

Read the full 200 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE